Philips CEO Sees Doubling of Sales Growth Rate as Unlikely -- Market Talk

Dow Jones
2025/12/04

1012 GMT - While Philips expects organic sales growth to improve in 2026, doubling of the growth rate is unlikely, Chief Executive Roy Jakobs told Citi analysts at the Global Healthcare Conference. Philips saw growth improve 1% in 2024 and guides for around 2% in 2025, Citi analysts say in a research note. The Dutch health-technology company's call of caution means that organic sales growth should be more than 2% but less than 4%, compared with company-compiled consensus of 4.5%, Citi says. Jakobs said the company still expects margins to expand in 2026, but tariff impacts will almost double year-on-year, Citi notes. Nevertheless, Citi sees Philips on track, the analysts say. Shares trade 7.4% lower at 22.27 euros. (nina.kienle@wsj.com)

 

(END) Dow Jones Newswires

December 04, 2025 05:16 ET (10:16 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10